DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $87,000 | -32.6% | 342 | -22.4% | 0.03% | -30.0% |
| Q1 2022 | $129,000 | -70.7% | 441 | -67.1% | 0.04% | -78.4% |
| Q4 2021 | $441,000 | -46.2% | 1,340 | -50.3% | 0.18% | -50.7% |
| Q3 2021 | $820,000 | +7.2% | 2,694 | -5.5% | 0.38% | +1.6% |
| Q2 2021 | $765,000 | -33.7% | 2,850 | -44.4% | 0.37% | -36.4% |
| Q1 2021 | $1,153,000 | +21.5% | 5,123 | +19.9% | 0.58% | -3.5% |
| Q4 2020 | $949,000 | -21.2% | 4,273 | -23.6% | 0.60% | -24.9% |
| Q3 2020 | $1,204,000 | +16.1% | 5,592 | -4.7% | 0.80% | +2.6% |
| Q2 2020 | $1,037,000 | +41.1% | 5,866 | +10.5% | 0.78% | +17.8% |
| Q1 2020 | $735,000 | -11.9% | 5,310 | -2.2% | 0.66% | +9.1% |
| Q4 2019 | $834,000 | -11.0% | 5,431 | -16.3% | 0.61% | -14.1% |
| Q3 2019 | $937,000 | -2.9% | 6,489 | -3.9% | 0.71% | -8.1% |
| Q2 2019 | $965,000 | +4.2% | 6,750 | -3.8% | 0.77% | +6.5% |
| Q1 2019 | $926,000 | +11.3% | 7,015 | -13.0% | 0.72% | +2.3% |
| Q4 2018 | $832,000 | -1.3% | 8,066 | -1.0% | 0.71% | +11.4% |
| Q3 2018 | $843,000 | +3.8% | 8,144 | -1.0% | 0.63% | +1.8% |
| Q2 2018 | $812,000 | +9.0% | 8,227 | +8.2% | 0.62% | +4.2% |
| Q1 2018 | $745,000 | +9.6% | 7,607 | +3.8% | 0.60% | +11.6% |
| Q4 2017 | $680,000 | -0.1% | 7,330 | -7.6% | 0.54% | -3.4% |
| Q3 2017 | $681,000 | +2.9% | 7,935 | +1.1% | 0.56% | -1.1% |
| Q2 2017 | $662,000 | +1.7% | 7,846 | +3.1% | 0.56% | -0.2% |
| Q1 2017 | $651,000 | +9.4% | 7,612 | -0.4% | 0.56% | +3.5% |
| Q4 2016 | $595,000 | – | 7,640 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |